These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 3511388

  • 1. Restricted recognition of beta 2-microglobulin by cytotoxic T lymphocytes.
    Rammensee HG, Robinson PJ, Crisanti A, Bevan MJ.
    Nature; ; 319(6053):502-4. PubMed ID: 3511388
    [Abstract] [Full Text] [Related]

  • 2. Creating CTL targets with epitope-linked beta 2-microglobulin constructs.
    Uger RA, Barber BH.
    J Immunol; 1998 Feb 15; 160(4):1598-605. PubMed ID: 9469415
    [Abstract] [Full Text] [Related]

  • 3. Recognition of the beta-2 microglobulin-B molecule by a CTL clone.
    Kurtz ME, Martin-Morgan D, Graff RJ.
    J Immunol; 1987 Jan 01; 138(1):87-90. PubMed ID: 3537130
    [Abstract] [Full Text] [Related]

  • 4. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
    Zügel U, Schoel B, Kaufmann SH.
    J Immunol; 1994 Nov 01; 153(9):4070-80. PubMed ID: 7523514
    [Abstract] [Full Text] [Related]

  • 5. IFN-gamma-induced recognition of the antigen-processing variant CMT.64 by cytolytic T cells can be replaced by sequential addition of beta 2 microglobulin and antigenic peptides.
    Jefferies WA, Kolaitis G, Gabathuler R.
    J Immunol; 1993 Sep 15; 151(6):2974-85. PubMed ID: 8397249
    [Abstract] [Full Text] [Related]

  • 6. Exogenous beta 2-microglobulin is required for antigenic peptide binding to isolated class I major histocompatibility complex molecules.
    Kane KP, Sherman LA, Mescher MF.
    Eur J Immunol; 1991 Sep 15; 21(9):2289-92. PubMed ID: 1889467
    [Abstract] [Full Text] [Related]

  • 7. Beta 2-microglobulin restriction of antigen presentation.
    Pérarnau B, Siegrist CA, Gillet A, Vincent C, Kimura S, Lemonnier FA.
    Nature; 1990 Aug 23; 346(6286):751-4. PubMed ID: 1697039
    [Abstract] [Full Text] [Related]

  • 8. Allospecific cytotoxic T cells generated from beta 2m-/- mice in primary MLC: analysis of activation requirements, specificity, and phenotype.
    Lamousé-Smith E, McCarthy SA.
    Cell Immunol; 1997 Aug 01; 179(2):107-15. PubMed ID: 9268494
    [Abstract] [Full Text] [Related]

  • 9. Polymorphism at position nine of the MHC class I heavy chain affects the stability of association with beta 2-microglobulin and presentation of a viral peptide.
    Ribaudo RK, Margulies DH.
    J Immunol; 1995 Oct 01; 155(7):3481-93. PubMed ID: 7561043
    [Abstract] [Full Text] [Related]

  • 10. Major histocompatibility complex class I-specific and -restricted killing of beta 2-microglobulin-deficient cells by CD8+ cytotoxic T lymphocytes.
    Glas R, Franksson L, Ohlén C, Höglund P, Koller B, Ljunggren HG, Kärre K.
    Proc Natl Acad Sci U S A; 1992 Dec 01; 89(23):11381-5. PubMed ID: 1454824
    [Abstract] [Full Text] [Related]

  • 11. Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction.
    Shirai M, Vacchio MS, Hodes RJ, Berzofsky JA.
    J Immunol; 1993 Aug 15; 151(4):2283-95. PubMed ID: 7688397
    [Abstract] [Full Text] [Related]

  • 12. Induction of peptide-specific CD8+ CTL clones in beta 2-microglobulin-deficient mice.
    Cook JR, Solheim JC, Connolly JM, Hansen TH.
    J Immunol; 1995 Jan 01; 154(1):47-57. PubMed ID: 7995959
    [Abstract] [Full Text] [Related]

  • 13. Demonstration of a murine cell surface component with affinity for exogenous beta 2-microglobulin.
    Sege K, Ostberg L, Peterson PA.
    Eur J Immunol; 1979 Dec 01; 9(12):964-71. PubMed ID: 95108
    [Abstract] [Full Text] [Related]

  • 14. Association of serum beta 2-microglobulin with H-2 class I heavy chains on the surface of mouse cells in culture.
    Kubota K.
    J Immunol; 1984 Dec 01; 133(6):3203-10. PubMed ID: 6436377
    [Abstract] [Full Text] [Related]

  • 15. Beta 2M-/- knockout mice contain low levels of CD8+ cytotoxic T lymphocyte that mediate specific tumor rejection.
    Lamousé-Smith E, Clements VK, Ostrand-Rosenberg S.
    J Immunol; 1993 Dec 01; 151(11):6283-90. PubMed ID: 8245467
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N, Fontaine P, Perreault C.
    Transplantation; 1994 Jul 15; 58(1):59-67. PubMed ID: 8036709
    [Abstract] [Full Text] [Related]

  • 18. Peptide-priming of cytolytic T cell immunity in vivo using beta 2-microglobulin as an adjuvant.
    Rock KL, Fleischacker C, Gamble S.
    J Immunol; 1993 Feb 15; 150(4):1244-52. PubMed ID: 8381832
    [Abstract] [Full Text] [Related]

  • 19. V beta 5+ T cell receptors skew toward OVA+H-2Kb recognition.
    Dillon SR, Jameson SC, Fink PJ.
    J Immunol; 1994 Feb 15; 152(4):1790-801. PubMed ID: 8120388
    [Abstract] [Full Text] [Related]

  • 20. Peptides control the gain and loss of allele specificity by mutated MHC class I molecules.
    Hengel H, Burke K, Kyburz D, Zinkernagel RM, Koszinowski UH.
    J Immunol; 1995 May 01; 154(9):4557-64. PubMed ID: 7722309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.